BTI
BIO icon

Blue Trust Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History

Blue Trust Inc’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$461K Buy
1,571
+18
+1% +$5.11K ﹤0.01% 517
2026
Q1 		$433K Buy
1,553
+123
+9% +$35.4K 0.01% 524
2025
Q4 		$433K Sell
1,430
-177
-11% -$55.2K ﹤0.01% 535
2025
Q3 		$451K Buy
1,607
+90
+6% +$24.5K 0.01% 526
2025
Q2 		$366K Buy
1,517
+79
+5% +$18.7K ﹤0.01% 562
2025
Q1 		$350K Buy
1,438
+374
+35% +$113K ﹤0.01% 520
2024
Q4 		$350K Buy
1,064
+8
+0.8% +$2.71K ﹤0.01% 483
2024
Q3 		$288K Buy
1,056
+197
+23% +$62.6K ﹤0.01% 696
2024
Q2 		$297K Buy
859
+143
+20% +$41.6K ﹤0.01% 559
2024
Q1 		$248K Buy
716
+236
+49% +$77.6K ﹤0.01% 441
2023
Q4 		$172K Buy
480
+142
+42% +$44.5K ﹤0.01% 494
2023
Q3 		$128K Buy
338
+239
+241% +$92.2K ﹤0.01% 551
2023
Q2 		$47K Sell
99
-569
-85% -$232K ﹤0.01% 711
2023
Q1 		$281K Buy
668
+158
+31% +$74K ﹤0.01% 428
2022
Q4 		$213K Buy
510
+278
+120% +$112K ﹤0.01% 430
2022
Q3 		$115K Buy
232
+49
+27% +$24.4K ﹤0.01% 481
2022
Q2 		$103K Buy
+183
New +$95.3K ﹤0.01% 484

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Blue Trust Inc's BIO Position: Q2 2026 in Review

Blue Trust Inc increased its Bio-Rad Laboratories Class A (BIO) stake by 1.2% in Q2 2026, buying an estimated $5.11K and bringing the position to 1,571 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

Blue Trust Inc first reported a position in BIO in Q2 2022 and has held it in 17 quarters since. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Blue Trust Inc held 1,571 shares of Bio-Rad Laboratories Class A worth $461K as of Q2 2026.
  • Blue Trust Inc bought 18 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $5.11K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #517 holding.
  • Blue Trust Inc first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and has held it in 17 quarters since.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.